Vaccines & Cell Therapies

To inquire about our available technologies, call our office (813) 745-6828

Name & Description Number
Vaccine Adjuvant: Flagellin-Based Adjuvant for Tumor Cell Vaccines 04A028
Antibodies: MARCO for Enhanced Dendritic Cell Vaccine Efficacy 07MB004
Vaccine: Bioengineered Dendritic Cell Vaccine for the Treatment of Cancer that Creates Functional Lymph-Node like Structures (“Designer Lymph Nodes”) 08MB008
Vaccine: Vaccines Using Synthetic Peptide-Poly IC Complexes that Elicit T-cell Responses Comparable to Live Vaccination 11MA013
 Vaccine: Use of a Variant Survivin Vaccine to Treat Myeloma 14MB098
TLR9: CARs (chimeric antigen receptors) that Recognize TLR9 16MA025
AaPC: Artificial Antigen-Presenting Cells with Heparin-Binding Domain for Producing CAR-Ts 16MB049
AaPC: Artificial Antigen-Presenting Cells for Expanding TILs/MILs in Cancer Immunotherapy 16MB050
TAG72: CAR-T cell constructs (chimeric antigen receptors) that Recognize TAG72 16MB057
IL-13Rα2: CAR-T cell constructs (chimeric antigen receptors) that Recognize IL-13Rα2 16MB069
TIM3: CAR-T cell constructs (chimeric antigen receptors) that Recognize TIM3 to treat AML 17MA008
CD33: CAR-T cell constructs  (chimeric antigen receptors) that Recognize CD33 to Treat AML 17MA030N
CD123: CAR-T cell constructs  (chimeric antigen receptors) that Recognize CD123 to Treat AML  17MA031N